Zimmer Biomet Holdings(ZBH-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low88.02
Day High90.59
Open:88.02
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Zacks Investment Research
ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
ISRG vs. ZBH: Which Robotic Surgery Stock Offers Better Upside Now?
Tipranks
Zimmer Biomet Holdings (ZBH) Receives a Hold from Bank of America Securities
Tipranks
Zimmer Biomet’s Sidus Stem-Free Shoulder Study Update: What Investors Should Know
Zacks Investment Research
Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom
Here's How GMED Is Capitalizing on the Musculoskeletal Market Boom
Zacks Investment Research
Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?
Will ISRG's Cost Leverage Aid Margins Amid Tariff & Input Inflation?
Tipranks
Wells Fargo Gives a Hold Rating to Zimmer Biomet Holdings (ZBH)
Zacks Investment Research
Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?
Should You Buy, Hold or Sell GMED Stock Amid Musculoskeletal Boom?
StockStory
2 Profitable Stocks to Consider Right Now and 1 We Question
MRVL
Tipranks
Zimmer Biomet Shareholders Reaffirm Board, Leadership and Oversight
StockStory
3 Healthcare Stocks That Fall Short
ENOV
StockStory
3 Reasons to Sell ZBH and 1 Stock to Buy Instead
ZBH
Tipranks
Zimmer Biomet Completes Key Post‑Market Study on ZNN Bactiguard Nails
Zacks Investment Research
ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now?
ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now?
Tipranks
Zimmer Biomet Expands 2026 Share Repurchase Program
StockStory
Why Zimmer Biomet (ZBH) Stock Is Up Today
ZBH
StockStory
3 Out-of-Favor Stocks We Approach with Caution
DPZ
StockStory
5 Revealing Analyst Questions From Zimmer Biomet’s Q1 Earnings Call
ZBH
Tipranks
Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Phathom Pharmaceuticals (PHAT) and Zimmer Biomet Holdings (ZBH)
Tipranks
Canaccord Genuity Sticks to Their Hold Rating for Zimmer Biomet Holdings (ZBH)

Profile

Zimmer Biomet is a leading musculoskeletal healthcare company that designs, manufactures and markets orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants; and related surgical products.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.